Tdap / Td ACIP Vaccine Recommendations
Advisory Committee for Immunization Practices (ACIP)
On this Page
![MMWR image](https://webarchive.library.unt.edu/web/20170127095558im_/https://www.cdc.gov/vaccines/hcp/acip-recs/images/mmwr-blue-logo.gif)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
CURRENT Tdap / Td Vaccine Recommendations
- MMWR, September 23, 2011, Vol 60, #37
FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
Print version [1.59MB, 32 pages] - MMWR, January 14, 2011, Vol 60, #01
Updated Tdap Vaccine Recommendations from the ACIP, 2010
Print version [1.18MB, 36 pages] - MMWR, August 1, 2008, Vol 57, #RR-06
Recommendations for Postexposure Interventions to Prevent Infection with Hepatitis B Virus, Hepatitis C Virus, or Human Immunodeficiency Virus, and Tetanus in Persons Wounded During Bombings and Other Mass-Casualty Events — United States, 2008
Print version [28 pages]
Adolescents
- MMWR, March 24, 2006, Vol 55, #RR-03
Preventing Tetanus, Diphtheria, and Pertussis Among ADOLESCENTS: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines- Appendix A | Appx B | Appx C | Appx D | Appx E | Appx F
Note: If you are using the HTML version of this document, be sure to access all links to get the complete content of the document, which includes 6 important appendices.
Print version [50 pages] (includes appendices) (summary)
- Appendix A | Appx B | Appx C | Appx D | Appx E | Appx F
Adults (under 65 years old)
- MMWR, December 15, 2006, Vol 55, #RR-17
Preventing Tetanus, Diphtheria, and Pertussis Among ADULTS: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines- Appendix A | Appendix B | Appendix C
Note: If you are using the HTML version of this document, be sure to access all links to get the complete content of the document, which includes important appendices.
- Appendix A | Appendix B | Appendix C
Adults 65 years and older
- MMWR, June 29, 2012, Vol 61, #25
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older, ACIP 2012
Print version [20 pages]
Tdap and Td Vaccines and Pregnancy
- MMWR, February 22, 2013, Vol 62, #7
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - ACIP, 2012
Print version [1.11MB, 28 pages] - MMWR, October 21, 2011, Vol 60, #41
Updated Recommendations for Use of Tdap in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months - ACIP, 2011
Print version [32 pages]
ARCHIVED Historical Tdap / Td Immunization Publications
For your convenience, these archived publications can be used for historical and research purposes.
- MMWR, April 17, 2009, Vol 58, #14
FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
Print version [2.07MB, 32 pages]
Tdap and Td Vaccines and Pregnancy Immunization
- MMWR, May 30, 2008, Vol 57, #4
Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants- Appendix A | Appendix B
- Print version [56 pages] (includes appendices)
- Page last reviewed: November 21, 2014
- Page last updated: December 22, 2014
- Content source: